| abstract |
The present invention includes at least one physiologically active substance, at least one skin permeation promoter, a pharmaceutically acceptable carrier comprising a volatile solvent, and a hydrocarbon fluorohydrocarbon propellant, wherein the carrier and permeation promoter are in combination with at least one physiologically active substance. A pharmaceutical composition for transdermal delivery is provided, which provides a single phase solution of. |